Quinoline derivative for treatment of triple-negative breast cancer
US-2020405709-A1 · Dec 31, 2020 · US
Chia Tai Tianqing Pharmaceutical Group Co Ltd was listed as an assignee on 50 patent publications in 2020.
| Metric | Value |
|---|---|
| Company | Chia Tai Tianqing Pharmaceutical Group Co Ltd |
| Year | 2020 |
| Patents | 50 |
Representative publications for Chia Tai Tianqing Pharmaceutical Group Co Ltd in 2020.
US-2020405709-A1 · Dec 31, 2020 · US
US-10875888-B2 · Dec 29, 2020 · US
US-10858340-B2 · Dec 8, 2020 · US
US-2020377517-A1 · Dec 3, 2020 · US
US-10851071-B2 · Dec 1, 2020 · US
Most common classification codes for Chia Tai Tianqing Pharmaceutical Group Co Ltd in 2020.
| CPC | Patents |
|---|---|
| A61P35/00 | 20 |
| C07D487/04 | 17 |
| C07B2200/13 | 14 |
| A61K31/519 | 12 |
| A61P31/12 | 8 |
Navigate to parent entity pages.